carbocyanines and viridin

carbocyanines has been researched along with viridin* in 1 studies

Other Studies

1 other study(ies) available for carbocyanines and viridin

ArticleYear
The antiproliferative cytostatic effects of a self-activating viridin prodrug.
    Molecular cancer therapeutics, 2009, Volume: 8, Issue:6

    Although viridins like wortmannin (Wm) have long been examined as anticancer agents, their ability to self-activate has only recently been recognized. Here, we describe the cytostatic effects of a self-activating viridin (SAV), which is an inactive, polymeric prodrug. SAV self-activates to generate a bioactive, fluorescent viridin NBD-Wm with a half-time of 9.2 hours. With cultured A549 cells, 10 micromol/L SAV caused growth arrest without inducing apoptosis or cell death, a cytostatic action markedly different from other chemotherapeutic agents (vinblastine, camptothecin, and paclitaxel). In vivo, a SAV dosing of 1 mg/kg once in 48 hours (i.p.) resulted in growth arrest of an A549 tumor xenograft, with growth resuming when dosing ceased. With a peak serum concentration of SAV of 2.36 micromol/L (at 2 hours post i.p. injection), the concentration of bioactive NBD-Wm was 41 nmol/L based on the partial inhibition of neutrophil respiratory burst. Therefore, SAV was present as an inactive prodrug in serum (peak = 2.36 micromol/L), which generated low concentrations of active viridin (41 nmol/L). SAV is a prodrug, the slow release and cytostatic activities of which suggest that it might be useful as a component of metronomic-based chemotherapeutic strategies.

    Topics: Androstenes; Animals; Bacteriocins; Blood Vessels; Carbocyanines; Cell Line; Cell Proliferation; Cytostatic Agents; Ear; Flow Cytometry; Half-Life; Humans; Injections, Intraperitoneal; Mice; Mice, Nude; Microscopy, Fluorescence; Molecular Structure; Neoplasms, Experimental; Peritoneum; Prodrugs; Tissue Distribution; Xenograft Model Antitumor Assays

2009